Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology

被引:19
|
作者
Kim, Jihoon [1 ]
Koo, Bon-Kyoung [1 ]
Yoon, Ki-Jun [2 ]
机构
[1] Austrian Acad Sci IMBA, Vienna Bioctr VBC, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria
[2] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea
来源
VIRUSES-BASEL | 2019年 / 11卷 / 02期
基金
欧洲研究理事会; 新加坡国家研究基金会;
关键词
organoid; host-virus interactions; CRISPR; Cas9 genome editing; induced pluripotent stem cell; adult stem cell; modeling of viral pathogenesis; LONG-TERM CULTURE; ZIKA-VIRUS; CEREBRAL ORGANOIDS; ROTAVIRUS INFECTION; NEURAL PROGENITORS; HUMAN NOROVIRUSES; DRUG-RESISTANCE; CRISPR-CAS9; IDENTIFICATION; NEUROGENESIS;
D O I
10.3390/v11020124
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pathologies induced by viral infections have undergone extensive study, with traditional model systems such as two-dimensional (2D) cell cultures and in vivo mouse models contributing greatly to our understanding of host-virus interactions. However, the technical limitations inherent in these systems have constrained efforts to more fully understand such interactions, leading to a search for alternative in vitro systems that accurately recreate in vivo physiology in order to advance the study of viral pathogenesis. Over the last decade, there have been significant technological advances that have allowed researchers to more accurately model the host environment when modeling viral pathogenesis in vitro, including induced pluripotent stem cells (iPSCs), adult stem-cell-derived organoid culture systems and CRISPR/Cas9-mediated genome editing. Such technological breakthroughs have ushered in a new era in the field of viral pathogenesis, where previously challenging questions have begun to be tackled. These include genome-wide analysis of host-virus crosstalk, identification of host factors critical for viral pathogenesis, and the study of viral pathogens that previously lacked a suitable platform, e.g., noroviruses, rotaviruses, enteroviruses, adenoviruses, and Zika virus. In this review, we will discuss recent advances in the study of viral pathogenesis and host-virus crosstalk arising from the use of iPSC, organoid, and CRISPR/Cas9 technologies.
引用
收藏
页数:17
相关论文
共 48 条
  • [1] Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems
    Antao, Ainsley Mike
    Karapurkar, Janardhan Keshav
    Lee, Dong Ryul
    Kim, Kye-Seong
    Ramakrishna, Suresh
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2020, 18 : 3649 - 3665
  • [2] Modeling Transient Abnormal Myelopoiesis Using Induced Pluripotent Stem Cells and CRISPR/Cas9 Technology
    Barwe, Sonali P.
    Sidhu, Ishnoor
    Kolb, E. Anders
    Gopalakrishnapillai, Anilkumar
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 19 : 201 - 209
  • [3] Generation of genetically modified mice using CRISPR/Cas9 and haploid embryonic stem cell systems
    Jin, Li-Fang
    Li, Jin-Song
    ZOOLOGICAL RESEARCH, 2016, 37 (04) : 205 - 213
  • [4] Generation of genetically modified mice using CRISPR/Cas9 and haploid embryonic stem cell systems
    Li-Fang JIN
    Jin-Song LI
    Zoological Research, 2016, 37 (04) : 205 - 213
  • [5] Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology
    Mianne, Joffrey
    Bourguignon, Chloe
    Van, Chloe Nguyen
    Fieldes, Mathieu
    Nasri, Amel
    Assou, Said
    De Vos, John
    CELLS, 2020, 9 (05)
  • [6] Discovery of Zika virus host dependency factors in trophoblasts using CRISPR/Cas9 screening
    Rother, Marion
    Dimmler, Christiane
    Weege, Friderike
    Mollenkopf, Hans-Joachim
    Meyer, Thomas F.
    Naumann, Michael
    JOURNAL OF VIROLOGICAL METHODS, 2021, 290
  • [7] Application and perspective of CRISPR/Cas9 genome editing technology in human diseases modeling and gene therapy
    Zhang, Man-Ling
    Li, Hong-Bin
    Jin, Yong
    FRONTIERS IN GENETICS, 2024, 15
  • [8] Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9
    Park, Chul-Yong
    Sung, Jin Jea
    Choi, Sang-Hwi
    Lee, Dongjin R.
    Park, In-Hyun
    Kim, Dong-Wook
    NATURE PROTOCOLS, 2016, 11 (11) : 2154 - 2169
  • [9] Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems
    Trevisan, Marta
    Sinigaglia, Alessandro
    Desole, Giovanna
    Berto, Alessandro
    Pacenti, Monia
    Palu, Giorgio
    Barzon, Luisa
    VIRUSES-BASEL, 2015, 7 (07): : 3835 - 3856
  • [10] Strengthening the CAR-T cell therapeutic application using CRISPR/Cas9 technology
    Sadeqi Nezhad, Muhammad
    Yazdanifar, Mahboubeh
    Abdollahpour-Alitappeh, Meghdad
    Sattari, Arash
    Seifalian, Alexander
    Bagheri, Nader
    BIOTECHNOLOGY AND BIOENGINEERING, 2021, 118 (10) : 3691 - 3705